e-learning
resources
Vienna 2012
Saturday, 01.09.2012
PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MDR-/XDR-TB: what are the unresolved problems in the clinical management?
J-P. Zellweger (Fribourg, Switzerland)
Source:
Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Session:
PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Session type:
Postgraduate Course
Number:
61
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J-P. Zellweger (Fribourg, Switzerland). MDR-/XDR-TB: what are the unresolved problems in the clinical management?. Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
What are the key questions in diagnosis and management?
Source: ERS Research Seminar 2017 – Precision medicine in airway diseases
Year: 2017
MDR-TB management: what is new?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017
Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations?
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005
From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control
Source: Annual Congress 2013 –The best of TB PANNET
Year: 2013
Challenges faced by Indian pediatricians in management of pediatric asthma in clinical practice.
Source: International Congress 2018 – Asthma and drugs
Year: 2018
Effective management of breathlessness: a review of potential human rights issues
Source: Eur Respir J, 49 (5) 1602099; 10.1183/13993003.02099-2016
Year: 2017
Tele-education in asthma management. What are the benefits?
Source: Annual Congress 2012 - Improving education for the healthcare team and patients
Year: 2012
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018
Preventing skin care issues associated with face masks used for domiciliary non-invasive ventilation: what do users and their carers think are the most relevant future research questions?
Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation
Year: 2019
Candidate selection and management: specific controversial and ethical issues
Source: ERS Course 2016
Year: 2016
Will clinicians keep their place in modern management of tuberculosis?
Source: Eur Respir J 2001; 18: Suppl. 33, 474s
Year: 2001
Spirometry in clinical use: practical issues
Source: Breathe 2010; 6: 196-203
Year: 2010
How do I manage NTM patients? Incorporating key learning from clinical cases
Source: ERS Course 2015
Year: 2015
Living with the challenges of treating tuberculosis: The patient and healthcare professional perspective
Source: Breathe 2015; 11:71-72
Year: 2015
Two major problems in TB patients today: MDR and the abandoned therapy
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
A clinical and aetiological evaluation of community acquired pneumonia-are we following guidelines in prescribing antibiotics?
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept